http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07309895-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95585944cd76ddfb6dc33ed2a0b84403 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 |
filingDate | 1994-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5d3edd6a69f3328b258ce809d8a32e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28d99712fffb40546fc76524de6d1f8 |
publicationDate | 1995-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H07309895-A |
titleOfInvention | Novel protein, its detection method and diagnostic agent |
abstract | (57) [Summary] [Objective] A novel protein that can be used as a marker for urinary system cancer including renal cancer and bladder cancer, for which a cancer marker has not been known, a method for detecting the protein, and a method for detecting the protein. To provide a urinary system cancer diagnostic agent that can [Structure] It is present in the urine of patients with urinary system cancer, is not detected in the urine of healthy humans, has a molecular weight of about 80 kDa, and has a molecular weight of 5.2. It has an isoelectric point between 0 and 6.50, and has anti-cathepsin B monoclonal antibody SBM1-1 (FERM P-136 83), SBM2-2 (FERM P-13682) and RB-1 (FERM P-13685), using an antigen-antibody-reactive protein, an antibody that reacts with the protein and an antigen-antibody, or an antigen-binding fragment thereof. And a method for detecting or quantifying the protein in a sample, and a urinary system cancer diagnostic agent containing an antibody that reacts with the protein in an antigen-antibody reaction or an antigen-binding fragment thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007026895-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013101611-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9902734-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6949357-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9851824-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9855656-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094881-A3 |
priorityDate | 1994-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.